Search Results 821-830 of 16450 for monoclonal antibody

1. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

   study drug. - Systemic cancer treatments, monoclonal antibody-directed therapies, other investigational agents within 4 weeks before enrollment, or <5 half ...

2. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...

3. Cryoglobulinemia - Symptoms and causes - Mayo Clinic

   There are three types of cryoglobulinemia. Type 1. This type has one kind of atypical protein, called monoclonal. Type 1 most often is linked to blood cancers.

4. Chemotherapy nausea and vomiting: Prevention is best defense - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth cancer · What is mouth cancer? A Mayo Clinic expert explains · Mouth cancer FAQs · Mouth sores caused ...

5. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   ... antibody. Eastern Cooperative Oncology Group (ECOG) performance status ... monoclonal antibodies ≤ 14 days prior to registration. Patients who have ...

6. MEETING THE CHALLENGES OF A HISTORIC YEAR: 2020 Mayo Clinic Performance Highlights

   ... monoclonal antibody treatments than any other health care organization, demonstrating a significant decrease in hospitalization rates and mortality.

7. Development of Potential COVID-19 Vaccine and Serological Assay - Mayo Clinic

   Our group has explored the use of genomic RNA/phage display libraries derived from primary human malignant melanoma cells as a means of identifying antibody ...

8. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

   Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...

9. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

   Prior monoclonal antibody within 4 weeks prior to study Day 1 (2 weeks for RS participants) or who has not recovered (i.e. ≤ Grade 1 or at baseline) from ...

10. Mayo Clinic Minute: What is CAR-T cell therapy?

    Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...